Arrowhead Research | ARWR - Attività Correnti





Attività Correnti Cambiamento Data
Agios Pharmaceuticals USD 752.1M 34.43M 2026-09
Alnylam Pharmaceuticals USD 5.11B 492.49M 2026-09
Anika Therapeutics USD 99.19M 5.63M 2026-06
Arrowhead Research USD 1.67B 168.34M 2026-06
Heron Therapeutics USD 229.84M 861K 2026-06
Incyte USD 5.52B 505.2M 2026-09
Ionis Pharmaceuticals USD 2.49B 446.73M 2026-06
Ligand Pharmaceuticals USD 608.23M 848.88M 2026-09
Merck USD 38.94B 2.26B 2026-09
Moderna USD 7.34B 1.53B 2026-09
Nektar Therapeutics USD 589.04M 322.77M 2026-03
Novartis USD 28.75B 1.4B 2026-09
Sarepta Therapeutics USD 2.27B 49.06M 2026-09
TG Therapeutics USD 1.15B 58.72M 2026-06
Ultragenyx Pharmaceutical USD 544M 62M 2026-09
Vertex Pharmaceuticals USD 11.69B 857.4M 2026-09
Xencor USD 498.66M 24.55M 2026-09